275 related articles for article (PubMed ID: 31396299)
1. Suppression of Alzheimer's Disease-Like Pathology Progression by Mitochondria-Targeted Antioxidant SkQ1: A Transcriptome Profiling Study.
Stefanova NA; Ershov NI; Kolosova NG
Oxid Med Cell Longev; 2019; 2019():3984906. PubMed ID: 31396299
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease-like pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondria-targeted antioxidant SkQ1.
Stefanova NA; Muraleva NA; Skulachev VP; Kolosova NG
J Alzheimers Dis; 2014; 38(3):681-94. PubMed ID: 24047616
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant SkQ1 Alleviates Signs of Alzheimer's Disease-like Pathology in Old OXYS Rats by Reversing Mitochondrial Deterioration.
Kolosova NG; Tyumentsev MA; Muraleva NA; Kiseleva E; Vitovtov AO; Stefanova NA
Curr Alzheimer Res; 2017; 14(12):1283-1292. PubMed ID: 28637402
[TBL] [Abstract][Full Text] [Related]
4. An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology.
Stefanova NA; Muraleva NA; Maksimova KY; Rudnitskaya EA; Kiseleva E; Telegina DV; Kolosova NG
Aging (Albany NY); 2016 Oct; 8(11):2713-2733. PubMed ID: 27750209
[TBL] [Abstract][Full Text] [Related]
5. Influence of Antioxidant SkQ1 on Accumulation of Mitochondrial DNA Deletions in the Hippocampus of Senescence-Accelerated OXYS Rats.
Loshchenova PS; Sinitsyna OI; Fedoseeva LA; Stefanova NA; Kolosova NG
Biochemistry (Mosc); 2015 May; 80(5):596-603. PubMed ID: 26071779
[TBL] [Abstract][Full Text] [Related]
6. Changes in Glial Support of the Hippocampus during the Development of an Alzheimer's Disease-like Pathology and Their Correction by Mitochondria-Targeted Antioxidant SkQ1.
Rudnitskaya EA; Burnyasheva AO; Kozlova TA; Peunov DA; Kolosova NG; Stefanova NA
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163053
[TBL] [Abstract][Full Text] [Related]
7. MEK1/2-ERK Pathway Alterations as a Therapeutic Target in Sporadic Alzheimer's Disease: A Study in Senescence-Accelerated OXYS Rats.
Muraleva NA; Kolosova NG; Stefanova NA
Antioxidants (Basel); 2021 Jun; 10(7):. PubMed ID: 34208998
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects induced by mitochondria-targeted antioxidant SkQ1 in Wistar and senescence-accelerated OXYS rats.
Stefanova NA; Fursova AZh; Kolosova NG
J Alzheimers Dis; 2010; 21(2):479-91. PubMed ID: 20555140
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic action of the mitochondria-targeted antioxidant SkQ1 on retinopathy in OXYS rats linked with improvement of VEGF and PEDF gene expression.
Markovets AM; Fursova AZ; Kolosova NG
PLoS One; 2011; 6(7):e21682. PubMed ID: 21750722
[TBL] [Abstract][Full Text] [Related]
10. Association of cerebrovascular dysfunction with the development of Alzheimer's disease-like pathology in OXYS rats.
Stefanova NA; Maksimova KY; Rudnitskaya EA; Muraleva NA; Kolosova NG
BMC Genomics; 2018 Feb; 19(Suppl 3):75. PubMed ID: 29504901
[TBL] [Abstract][Full Text] [Related]
11. SkQ1 Suppresses the p38 MAPK Signaling Pathway Involved in Alzheimer's Disease-Like Pathology in OXYS Rats.
Muraleva NA; Stefanova NA; Kolosova NG
Antioxidants (Basel); 2020 Jul; 9(8):. PubMed ID: 32731533
[TBL] [Abstract][Full Text] [Related]
12. The mitochondria-targeted antioxidant SkQ1 restores αB-crystallin expression and protects against AMD-like retinopathy in OXYS rats.
Muraleva NA; Kozhevnikova OS; Zhdankina AA; Stefanova NA; Karamysheva TV; Fursova AZ; Kolosova NG
Cell Cycle; 2014; 13(22):3499-505. PubMed ID: 25483086
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-targeted antioxidant SkQ1 inhibits age-dependent involution of the thymus in normal and senescence-prone rats.
Obukhova LA; Skulachev VP; Kolosova NG
Aging (Albany NY); 2009 Apr; 1(4):389-401. PubMed ID: 20195490
[TBL] [Abstract][Full Text] [Related]
14. Retinoprotective Effect of SkQ1, Visomitin Eye Drops, Is Associated with Suppression of P38 MAPK and ERK1/2 Signaling Pathways Activity.
Muraleva NA; Zhdankina AA; Fursova AZ; Kolosova NG
Biochemistry (Mosc); 2024 Feb; 89(2):201-211. PubMed ID: 38622090
[TBL] [Abstract][Full Text] [Related]
15. Effects of the mitochondria-targeted antioxidant SkQ1 on sexually motivated behavior in male rats.
Amstislavskaya TG; Maslova LN; Gladkikh DV; Belousova II; Stefanova NA; Kolosova NG
Pharmacol Biochem Behav; 2010 Aug; 96(2):211-6. PubMed ID: 20470816
[TBL] [Abstract][Full Text] [Related]
16. Ameliorative effects of SkQ1 eye drops on cataractogenesis in senescence-accelerated OXYS rats.
Rumyantseva YV; Ryabchikova EI; Fursova AZ; Kolosova NG
Graefes Arch Clin Exp Ophthalmol; 2015 Feb; 253(2):237-48. PubMed ID: 25267419
[TBL] [Abstract][Full Text] [Related]
17. Impact of Changes in Neurotrophic Supplementation on Development of Alzheimer's Disease-Like Pathology in Oxys Rats.
Rudnitskaya EA; Kolosova NG; Stefanova NA
Biochemistry (Mosc); 2017 Mar; 82(3):318-329. PubMed ID: 28320273
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-Targeted Antioxidant SkQ1 (10-(6´-Plastoquinonyl)decyltriphenylphosphonium Bromide) Inhibits Mast Cell Degranulation in vivo and in vitro.
Chelombitko MA; Averina OA; Vasilyeva TV; Pletiushkina OY; Popova EN; Fedorov AV; Chernyak BV; Shishkina VS; Ilinskaya OP
Biochemistry (Mosc); 2017 Dec; 82(12):1493-1503. PubMed ID: 29486699
[TBL] [Abstract][Full Text] [Related]
19. The mitochondria-targeted antioxidant SkQ1 but not N-acetylcysteine reverses aging-related biomarkers in rats.
Kolosova NG; Stefanova NA; Muraleva NA; Skulachev VP
Aging (Albany NY); 2012 Oct; 4(10):686-94. PubMed ID: 23104863
[TBL] [Abstract][Full Text] [Related]
20. The Rat Prefrontal-Cortex Transcriptome: Effects of Aging and Sporadic Alzheimer's Disease-Like Pathology.
Stefanova NA; Ershov NI; Maksimova KY; Muraleva NA; Tyumentsev MA; Kolosova NG
J Gerontol A Biol Sci Med Sci; 2019 Jan; 74(1):33-43. PubMed ID: 30265298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
